Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)
Samuel R Schnittman(Icahn School of Medicine at Mount Sinai), Steven Grinspoon(Massachusetts General Hospital), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Edgar T. Overton(University of Alabama at Birmingham), Beverly E. Sha(Rush University Medical Center), Borek Foldyna(Cancer Research And Biostatistics), Pamela S. Douglas(Duke University), Thomas Mayrhofer(Harvard University), Pablo Tebas(University of Pennsylvania), Evelynne S. Fulda(Cancer Research And Biostatistics), Michael T. Lu(Cancer Research And Biostatistics), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Jacqueline M Flynn(Temple University), Tricia H. Burdo(Temple University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Markella V. Zanni(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Kristine M. Erlandson(University of Colorado Denver)
Cited by 13
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k